Has it really been over 7 years?
Health Enhancement Products Announces Official Launch of ProAlgaZyme
30 March 2004, 08:30am ET
Product Sales Commenced and Targeted Advertising Campaign Initiated
TEMPE, Ariz., March 30 /PRNewswire-FirstCall/ - Nutraceutical company, Health Enhancement Products, Inc. (OTC: HEPI) today announced the official launch of the Company's flagship product, ProAglaZyme. Sales of ProAlgaZyme have also commenced through several U.S. distributors, as well as through the Company's website, www.heponline.com
.
The Company's targeted advertising campaign will focus on people with varying, serious illnesses, particularly those with weakened immune systems. The majority of the advertising campaign will be placed on high profile health and medical radio talk shows with audiences that closely match the Company's targeted consumer. Health Enhancement Products has also arranged for several live interviews. As a secondary phase of the advertising campaign, the Company has started marketing and selling ProAlgaZyme through Internet advertising. Initial ads will run via powerful, highly visited online sites such as FoxNews.com, NewsMax.com, and Politics.com, among others.
Howard Baer, Chief Executive Officer of Health Enhancement Products, Inc., stated, "This is an important step for us as it will be our first promotion specifically geared towards the sale of ProAlgaZyme. To date, our concentration has been strictly on in-house clinical studies, which have been very successful. We are now preparing the protocols and applications for independent, randomized, placebo-controlled, triple-blinded clinical trials. Given the success we have achieved internally we expect to see sales increase in relation to the advertising campaign. One fact that has been established thus far is that initial customers that have tried the product invariably come back to purchase more on a regular basis. As with all other consumer products, awareness is key. Our goal is to raise awareness in a cost effective manner, while also building relationships with long-term, repeat customers worldwide."
Baer continued, "In addition, we are currently running an introductory special with the purchase of ProAlgaZyme. For a limited time only, consumers can buy 1 bottle of ProAlgaZyme and get the 2nd free. As part of this promotion, we are offering a full money-back guarantee if the consumer doesn't feel better after taking the ProAlgaZyme. Orders can be placed online at
www.proalgazyme.com or at www.heponline.com , or by calling (866) ProAlgaZyme or (866) 776-2542. We expect a positive consumer response from this promotion, as our advertising campaign is already driving increased traffic to our website and interest in our products from prospective consumers. We view this initiative as just one part of what will be an ongoing, expanding sales and marketing effort to help support our growth."
About Health Enhancement Products, Inc.
Health Enhancement Products, Inc. (OTC: HEPI) is a nutraceutical company directed specifically at the development and marketing of supplementary health-enhancing products using only pure, all-natural and herbal extracts. In particular, Health Enhancement's products use beneficial herbal extracts, vitamins, minerals, and botanical extracts in varying combinations to address common or specific illnesses.
The Company's sole product is ProAlgaZyme that is produced from an algae grown in 100% distilled water. The algae produces an enzyme as a means of protecting itself from exposure to outside disease and harmful bacteria. The enzyme is then drawn off, filtered, tested and bottled for consumption. Recent clinical trials performed by the Company have indicated that ProAlgaZyme may increase and activate the white blood cells in individuals whose white cells are low or inactive, in effect enhancing the immune system. Heath Enhancements is currently doing internal clinical trials on several illnesses and diseases with ProAlgaZyme, including various types of cancer, HIV/AIDS, diabetes and Chronic Fatigue Syndrome.
ReplenTish is currently available for sale exclusively on
our websites www.heponline.com or www.replentish.com .
Recent ZIVO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 09:37:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 09:37:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 09:36:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 08:47:53 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 06/13/2024 12:49:08 AM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 06/07/2024 10:02:25 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 10:30:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 10:28:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 10:27:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 10:26:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 10:25:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 08:54:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 09:16:40 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 08:38:03 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/26/2024 05:36:56 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 04/09/2024 03:49:14 PM
- Form SCHEDULE 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 03/14/2024 01:16:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:45:37 PM
- Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities • Edgar (US Regulatory) • 02/15/2024 01:54:37 PM
- ZIVO Bioscience Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study • Business Wire • 02/07/2024 09:54:00 PM
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM